Free Trial

24,365 Shares in Sabra Healthcare REIT, Inc. $SBRA Purchased by Sequoia Financial Advisors LLC

Sabra Healthcare REIT logo with Finance background

Key Points

  • Sequoia Financial Advisors LLC acquired 24,365 shares of Sabra Healthcare REIT, valued at approximately $449,000, indicating growing interest from institutional investors in the company.
  • Sabra Healthcare REIT reported a quarterly earnings per share of $0.38, exceeding estimates, and has set a fiscal year 2025 guidance of 1.450-1.470 EPS.
  • The company announced a quarterly dividend of $0.30 per share, reflecting an annualized yield of 6.5%, although its dividend payout ratio is notably high at 157.89%.
  • MarketBeat previews the top five stocks to own by November 1st.

Sequoia Financial Advisors LLC purchased a new position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 24,365 shares of the real estate investment trust's stock, valued at approximately $449,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Bank of New York Mellon Corp boosted its holdings in shares of Sabra Healthcare REIT by 1.8% in the 1st quarter. Bank of New York Mellon Corp now owns 4,114,215 shares of the real estate investment trust's stock worth $71,875,000 after buying an additional 74,564 shares during the last quarter. Nuveen LLC purchased a new position in shares of Sabra Healthcare REIT in the 1st quarter worth about $61,791,000. Advisors Capital Management LLC boosted its holdings in shares of Sabra Healthcare REIT by 20.5% in the 1st quarter. Advisors Capital Management LLC now owns 2,232,609 shares of the real estate investment trust's stock worth $39,004,000 after buying an additional 380,505 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Sabra Healthcare REIT by 16.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,687,977 shares of the real estate investment trust's stock worth $29,489,000 after buying an additional 243,274 shares during the last quarter. Finally, Victory Capital Management Inc. boosted its holdings in shares of Sabra Healthcare REIT by 12.7% in the 1st quarter. Victory Capital Management Inc. now owns 1,630,076 shares of the real estate investment trust's stock worth $28,477,000 after buying an additional 183,739 shares during the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. National Bankshares set a $22.00 price target on shares of Sabra Healthcare REIT in a report on Friday. Cantor Fitzgerald assumed coverage on shares of Sabra Healthcare REIT in a report on Wednesday, October 1st. They set a "neutral" rating and a $20.00 price objective on the stock. Scotiabank upped their price objective on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a report on Monday, June 23rd. BMO Capital Markets upped their price objective on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a report on Monday, August 25th. Finally, Truist Financial upped their price objective on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a "hold" rating in a report on Tuesday, September 2nd. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $20.88.

Check Out Our Latest Stock Analysis on Sabra Healthcare REIT

Sabra Healthcare REIT Price Performance

Shares of NASDAQ:SBRA opened at $18.43 on Tuesday. The company has a 50 day moving average of $18.68 and a 200 day moving average of $18.20. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. The stock has a market cap of $4.42 billion, a P/E ratio of 24.25, a P/E/G ratio of 1.22 and a beta of 0.85. Sabra Healthcare REIT, Inc. has a 12 month low of $15.60 and a 12 month high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.02. The business had revenue of $189.15 million for the quarter, compared to analyst estimates of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. Sabra Healthcare REIT's revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.5%. The ex-dividend date of this dividend was Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio is 157.89%.

Sabra Healthcare REIT Company Profile

(Free Report)

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

See Also

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Sabra Healthcare REIT Right Now?

Before you consider Sabra Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.

While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.